Digirad closes DMS Health acquisition
Digirad Corporation, a Suwanee, Ga.-based developer and manufacturer of diagnostic imaging systems, announced this week that it has officially closed its acquisition of DMS Health Technologies. The deal, first announced back in October 2015, was for $36 million.
The combined company is expected to generate more than $125 million in pro forma annual revenue.
Matt Molchan, Digirad president and CEO, said at the time of the announcement that acquiring DMS Health was a significant transaction for both the present and future of the company.
“We believe this acquisition represents a significant milestone in Digirad’s history, and should generate considerable value for our customers and our shareholders and enhanced opportunities for the employees of both companies,” commented Matt Molchan, Digirad’s President and CEO. “The integration of DMS Health and Digirad will enable the combined company to expand its range of customers serviced as well as provide significant geographical and service level diversification. DMS Health is an ideal strategic fit for us and our commitment to providing healthcare solutions on an as needed, when needed, and where needed basis.”
William Vogel, DMS Health CEO, also commented on the deal when it was first announced.
“Today is an exciting day for the entire DMS Health team and for the future of our company,” Vogel said in a statement. “Digirad is an ideal fit for our company; they know the industry and our market very well, and we believe the Digirad team is uniquely suited to help us grow in the future.”
Additional coverage of Digirad’s deal with DMS Health can be read here.
Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.